HopeStage
Back to all studies
CompletedNCT00411463

Interpersonal and social rhythm therapy for bipolarity type II depression

About this titleRead the official source — NCT00411463
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
PittsburghSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2006
Recruitment status
Completed
Enrollment listed in the registry
25
Sponsor
University of Pittsburgh
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00411463
Official title
Show the full official title

Psychotherapy for Bipolar II Depression, Pilot Study, Phase II

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pittsburgh, a university.

Did this study involve medication?

Yes. The study involved medication, including Seroquel.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies